Brand check

Is Calpol banned in India?

Last checked 1 October 2026

Calpol. Status: Not banned.

Calpol is not banned in India as of 1 Oct 2026; it is single-ingredient paracetamol, which no Section 26A notification covers.

Classification
No ban or recall found in official records
Decided by
CDSCO / Ministry of Health and Family Welfare
Reference
No Section 26A notification for paracetamol
Evidence
Government document
Latest action
4 October 2025
Last checked
1 October 2026

Calpol Six Plus advertisement (Wellcome Collection). Photo: Calpol Six Plus Wellcome L0068137.jpg by Unknown author (CC BY 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.

Primary government sourceTier 1: government primary source

CDSCO: Drugs banned in India (consumer section)

CDSCO / Ministry of Health and Family Welfare · No Section 26A notification for paracetamol

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.

Key facts

Governing authority
CDSCO, Ministry of Health and Family Welfare
Ban notification
None
Marketer
GSK / Haleon (India)
Paediatric syrup
Not covered by the Oct 2025 DGHS advisory, which concerns cough syrups
NSQ history
Check individual batches against CDSCO monthly alerts

Where the claim comes from

Calpol is the paracetamol brand most associated with children, so the October 2025 advisory against cough syrups for under-2s and the 2025 to 2026 restrictions on chlorpheniramine + phenylephrine drops for under-4s produced 'is Calpol banned' searches. Neither action concerns paracetamol. The 2022 Dolo tax story and the 2024 FDC list added to it.

Calpol is a paracetamol brand sold as tablets and as a paediatric syrup. It is not banned in India, and no regulator has proposed banning it.

The government's recent actions on children's medicines are the reason for the question. On 4 October 2025 the Directorate General of Health Services advised that cough syrups should not be prescribed or dispensed to children below two years, after the deaths linked to diethylene-glycol-contaminated syrups. In April 2025 and again in August 2026 the Health Ministry required chlorpheniramine + phenylephrine products to carry a "not for children below four years" label. Both measures concern cough and cold products. Paracetamol syrup is a fever and pain medicine and is outside both.

Single-ingredient paracetamol has never been the subject of a Section 26A notification. The various FDC bans since 2016 removed combinations in which paracetamol is mixed with decongestants, antihistamines, muscle relaxants or opioids; they did not touch paracetamol alone.

What parents should still do is ordinary: dose by weight as advised, keep to the interval on the label, and check the batch number if a CDSCO alert names a paracetamol product. Batch-level findings, when they occur, are about one production lot, not the brand.

What this means for you

Safe to continue as directed

Calpol syrup and tablets are licensed; dose by weight for children as your doctor advised.

It is not a cough syrup

The 2025 advisory and the 2025 to 2026 label rules for children concern cough and cold combinations, not paracetamol.

This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.

Batches flagged in CDSCO alerts

Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.

Product Batch Manufacturer Reason declared NSQ Tested by Alert
Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate and Caffeine Tablets Batch DRT25284Mfg Sep 2025 · Exp Aug 2027 Eastern HealthcareUttarakhand DescriptionDescription RDTL, Bellary, KarnatakaState lab Sep 2026
Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets Batch DHPLT/030725Mfg Jul 2025 · Exp Jun 2027 Durgaji Healthcare Pvt.LtdUttarakhand The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Acts and rules 1945 with respect to test for 'Disintegration Time' and is also not of standard quality for the reason stated under 'Description'.Description CDL, KolkataCDSCO lab Sep 2026
Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension Batch SKL260238Mfg Mar 2026 · Exp Feb 2028 S Kins PharmaHimachal Pradesh The sample does not coform to the claim to the prescribed standard for Patent & Proprietary medicine with respect to the assay of menthol.Assay Drug Testing Laboratory, Baddi, Solan, H.PState lab Sep 2026
Paracetamol Tablets IP 650 mg, Batch CAAL25019Mfg Apr 2025 · Exp Mar 2028 Curetech Formulations Pvt. LtdHimachal Pradesh Sample does not conform to IP standards. It fails the test Dissolution.Dissolution RDTL , ErnakulamState lab Sep 2026
Paracetamol Tablets IP 650 mg Batch TV6122Mfg Aug 2026 · Exp Jul 2028 Alpa Laboratories LtdMadhya Pradesh The sample does not conform to IP with respect to the DissolutionDissolution SDTL, GuwahatiState lab Sep 2026
Paracetamol Tablets IP 650 mg Batch IPCL25017Mfg Mar 2025 · Exp Feb 2028 Pinnacle Life Science Pvt LtdHimachal Pradesh Test for DissolutionDissolution RDTL, Bellary, KarnatakaState lab Sep 2026
Paracetamol Tablets IP 500mg Batch PCTJ26007Mfg Mar 2026 · Exp Feb 2028 Vivek Pharmaceuticals Pvt. LtdJammu & Kashmir The sample does not conform to IP with respect to the DissolutionDissolution SDTL, GuwahatiState lab Sep 2026
Paracetamol Tablets IP 500 mg Batch PAK-815Mfg Nov 2024 · Exp Oct 2027 Healer's Lab Unit IIHimachal Pradesh The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution DTL, ThrissurState lab Sep 2026
Paracetamol Sustained Release Tablets USP Batch BRD240848AMfg Dec 2024 · Exp Nov 2027 BRD Medilabs (Unit-II)Himachal Pradesh Sample does not conform to USP Standards. It fails the test Dissolution as per USP.Dissolution RDTL , ErnakulamState lab Sep 2026
Paracetamol Phenylepherine Hydrochloride Caffine (Anhydrous) Diphenhydramine Hydrochloride Batch T-2511129Mfg Nov 2025 · Exp Oct 2027 Aagya Biotech Pvt. Ltd. 1.5 kmUttarakhand DescriptionDescription SDT&RL, BhubanesearState lab Sep 2026
Paracetamol Paediatric Oral Suspension IP Batch PAMLA002Mfg Aug 2025 · Exp Jul 2027 Laborate Pharmaceuticals India LtdHimachal Pradesh The sample does not conform to IP in respect of content of Paracetamol.Other LUCKNOW, Uttar PradeshState lab Sep 2026
Paracetamol IP 500 mg Tablets Batch APRCT-2501Mfg May 2025 · Exp Apr 2027 Konis Pharmaceuticals Pvt. LtdHimachal Pradesh Sample Does not meets the Specifications wrt, Assay and Dissolution Test as per IP.Assay State Lab, DCL, TelanganaState lab Sep 2026
PARACETAMOL PAEDIATRIC ORAL SUSPENSION Batch PAD1130Mfg Feb 2026 · Exp Jan 2028 REVIVE Formulations India Pvt. LtdTamil Nadu Misbranded-Incorrect LabellingMisbranded DTL, PuducherryState lab Sep 2026
PARACETAMOL AND TRAMADOL TABLETS IP Batch DT644Mfg Jul 2025 · Exp Jun 2027 Prim Drugs & Pharmaceuticals (I) Pvt. LtdTamil Nadu Failed Disintegration and DissolutionDissolution DTL, PuducherryState lab Sep 2026
Meloxicam, Paracetamol And Serratiopeptidase Bolus (Vet) Batch PT25367Mfg Dec 2025 · Exp May 2028 Prispag PharmaPunjab Uneven Light Brown Coloured Spots are observed on the Surface of Almost all the Bolus.Description FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab Sep 2026
Meloxicam and Paracetamol Bolus (Vet) Batch Nov-21Mfg Apr 2026 · Exp Mar 2028 Unitech Pharmaceuticals (India) DescriptionDescription RDTL, Bellary, KarnatakaState lab Sep 2026
Mefenamic Acid and Paracetamol Tablets Batch T3209Mfg May 2024 · Exp Apr 2027 Jersy Pharma Assay for Mefenamic AcidAssay DTL, Bengaluru, KarnatakaState lab Sep 2026
Ibuprofen &Paracetamol Tablets IP Batch KFM-2501Mfg Mar 2025 · Exp Feb 2028 Askon Health Care The sample does not conform to standard quality in respect of the test for ?Dissolution? and Description performed.Dissolution SDTL, Agartala, TripuraState lab Sep 2026
Ibuprofen & Paracetamol Tablets Batch OT-13158Mfg Jun 2026 · Exp May 2028 Omnison Pharma (P) Ltd. G-456 & 457 The sample does not conform to standard, in respect of Uniformity of Dispersion.Uniformity of weight/content LUCKNOW, Uttar PradeshState lab Sep 2026
Flupirtine Maleate and Paracetamol Tablets Batch T26H291Mfg Aug 2026 · Exp Jul 2028 Dr. ARS (India) Labs Pvt Ltd Content of Flupirtine MaleateOther Drugs Testing Laboratory,Madurai-19State lab Sep 2026
Showing 20 of 40 records

Ingredient records: Paracetamol

Sources

Government documents

News reports